Therapeutic potential of GLP-1 receptor agonists and SGLT2 inhibitors in diabetic neuropathy: a critical appraisal
- DOI
- 10.1186/s13098-026-02241-w
- Published
- 2026-07-30
- Container
- Diabetology & Metabolic Syndrome
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s13098-026-02241-w,
title = {Therapeutic potential of GLP-1 receptor agonists and SGLT2 inhibitors in diabetic neuropathy: a critical appraisal},
author = {Dan Ziegler and Peter Kempler and Cornelia Bala and Boris Mankovsky and Oliver Schnell and Vincenza Spallone and Alin Stirban and Solomon Tesfaye},
year = {2026},
journal = {Diabetology \& Metabolic Syndrome},
doi = {10.1186/s13098-026-02241-w},
url = {https://doi.org/10.1186/s13098-026-02241-w}
}RIS
TY - JOUR TI - Therapeutic potential of GLP-1 receptor agonists and SGLT2 inhibitors in diabetic neuropathy: a critical appraisal AU - Dan Ziegler AU - Peter Kempler AU - Cornelia Bala AU - Boris Mankovsky AU - Oliver Schnell AU - Vincenza Spallone AU - Alin Stirban AU - Solomon Tesfaye PY - 2026 JO - Diabetology & Metabolic Syndrome DO - 10.1186/s13098-026-02241-w UR - https://doi.org/10.1186/s13098-026-02241-w ER -
APA
Ziegler, D., Kempler, P., Bala, C., Mankovsky, B., Schnell, O., Spallone, V., Stirban, A., & Tesfaye, S. (2026). Therapeutic potential of GLP-1 receptor agonists and SGLT2 inhibitors in diabetic neuropathy: a critical appraisal. Diabetology & Metabolic Syndrome. https://doi.org/10.1186/s13098-026-02241-w
Source records
- crossref · retrieved 2026-09-26T02:00:59.908Z